Policies & Disclaimers  |  Contact Us  |  Site Map  |  Important Safety Information   
Inhaled Ventavis® (iloprost) Inhalation Solution Breathe In the Power of Prostacyclin In Pulmonary Arterial Hypertension (PAH) NYHA Class III or IV
     Efficacy
PAH Pathways - Actelion Services & Support
Download 20 mcg/mL Medication Order Form
Download the
Ventavis Patient
Enrollment Forms

Efficacy

Ventavis® (iloprost) Inhalation Solution is a synthetic analogue of prostacyclin PGI2.1 It dilates system and pulmonary arterial vascular beds. It also affects platelet aggregation, although the relevance of this effect to the treatment of pulmonary arterial hypertension is unknown.1

In clinical studies, Ventavis has been shown to help with the following1,2:

  • Significant improvement in a composite endpoint of patient improvement—improvement in functional class, 10% or greater increase in individual walk distance, and lack of clinical deterioration or death (p=0.0033)1,2*
  • Significant improvement in exercise capacity (p<0.01)1,2*
  • Significant improvement in NYHA functional class (p=0.03)1,2

Read more about How Ventavis Helps Patients:

1. Ventavis (iloprost) Full Prescribing Information. Actelion Pharmaceuticals US, Inc. 2009.
2. Olschewski H, Simonneau G, Galie N et al, for the Aerosolized Iloprost Randomized Study Group. Inhaled iloprost for severe pulmonary hypertension. N Engl J Med. 2002;347:322-329.



ACTELION